Cytokine profiling in anti neutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional cohort study

被引:21
|
作者
Hoffmann, Johanna Charlotte [1 ]
Patschan, Daniel [2 ]
Dihazi, Hassan [1 ]
Mueller, Claudia [1 ]
Schwarze, Katrin [1 ]
Henze, Elvira [1 ]
Ritter, Oliver [2 ]
Mueller, Gerhard Anton [1 ]
Patschan, Susann [1 ]
机构
[1] Univ Hosp Gottingen, Clin Nephrol & Rheumatol, Gottingen, Germany
[2] Med Hsch Brandenburg, Klinikum Brandenburg, Zentrum Innere Med 1, Cardiol,Angiol,Nephrol, Hochstr 29, D-14770 Brandenburg, Germany
关键词
AAV; Cytokines; VDI; BVAS; ANCA-ASSOCIATED VASCULITIS; EOSINOPHILIC GRANULOMATOSIS; DISEASE-ACTIVITY; CYCLOPHOSPHAMIDE; POLYANGIITIS; ACTIVATION; INTERLEUKIN-10; BIOACTIVITY; RITUXIMAB; THERAPY;
D O I
10.1007/s00296-019-04364-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ANCA-associated vasculitides (AAV) are severe diseases, potentially affecting lungs, kidney, and other organs. Nevertheless, risk profiling remains difficult. Aim of the current study was to analyze serological characteristics in AAV. The principal goal was to identify diagnostic markers that potentially allow a more sophisticated risk profiling in AAV. AAV subjects were recruited and evaluated for disease activity, disease stage, medication, and laboratory findings. Serum concentrations of the following parameters were measured: IL-1 beta, IL-6, IL-17 A, IL-17 F, IL-21, IL-22, IL-23, TNF-alpha, sCD40L, IL-4, IL-10, IL-25, IL-31, IL-33, and INF-gamma. A total number of 62 AAV subjects was included in the study (39 females; 23 males). Forty-five subjects were PR3+, 17 subjects showed ANCA specificity for MPO. The majority of all cytokines fell under the lower detection limit of the assay. Serum IL-10 was higher in both, AAV and SSc as compared to controls; it was also higher in early systemic AAV. Serum IL-33 was elevated in AAV and SSc; in AAV, higher levels were found in non-necrotizing GN and RTX untreated subjects. Serum CD40L was raised in AAV as well; higher concentrations were also found in PR3+ and MPO+ patients and early systemic, generalized, and refractory AAV. IL-10 may potentially serve as a marker of early systemic AAV. IL-33 may help to identify subjects with a higher risk for necrotizing GN in AAV.
引用
收藏
页码:1907 / 1917
页数:11
相关论文
共 50 条
  • [1] Cytokine profiling in anti neutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional cohort study
    Johanna Charlotte Hoffmann
    Daniel Patschan
    Hassan Dihazi
    Claudia Müller
    Katrin Schwarze
    Elvira Henze
    Oliver Ritter
    Gerhard Anton Müller
    Susann Patschan
    [J]. Rheumatology International, 2019, 39 : 1907 - 1917
  • [2] Lipid Profiles in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: A Cross-sectional Analysis
    Ahn, Sung Soo
    Yoon, Taejun
    Song, Jason Jungsik
    Park, Yong-Beom
    Lee, Sang-Won
    [J]. JOURNAL OF RHEUMATIC DISEASES, 2020, 27 (04): : 261 - 269
  • [3] Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Sun, Xiao-Jing
    Li, Zhi-Ying
    Chen, Min
    [J]. RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (01): : 11 - 21
  • [4] A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Moura, Marta Casal
    Branco, Carolina
    Martins-Martinho, Joana
    Ferraro, Jose Luis
    Berti, Alvise
    Nogueira, Estela
    Ponte, Cristina
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [5] Influenza vaccination and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Wiwanitkit, Viroj
    [J]. NEPHROLOGY, 2015, 20 (07) : 511 - 512
  • [6] Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Richard W. Lee
    David P. D’Cruz
    [J]. Drugs, 2008, 68 : 747 - 770
  • [7] AN OVERVIEW OF PHARMACOTHERAPY FOR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Stasi, R.
    [J]. DRUGS OF TODAY, 2010, 46 (12) : 919 - 928
  • [8] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [9] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Tervaert, JWC
    Stegeman, CA
    Kallenberg, CGM
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 211 - 217
  • [10] Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Gan, Poh-Yi
    Ooi, Joshua D.
    Kitching, A. Richard
    Holdsworth, Stephen R.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2380 - 2390